NCT05470062

Brief Summary

This study aims to explore the effects of arch support insoles on balance and gait performance in older adults with mild cognitive impairment (MCI). We will recruit 40 female older adults with MCI. A randomized crossover trial will be used to determine the immediate effect of arch support insoles. All participants received one assessment session wearing and one session not wearing insole in a random order within 1-day. Then participants will be randomly allocated to experimental group (arch support insoles, n=20) or control group (no insoles, n=20) for at least 4-h every day for 1-month. Our primary outcomes include static standing balance, timed-up-and-go test, 10-m obstacle crossing, functional reach test, Short Physical Performance Battery (SPPB), and gait assessment during single- and dual-task walking for 20 m at self-selected comfortable pace while performing serial subtractions (cognitive interference) or carrying a tray (motor interference). Assessments will be conducted at baseline and after 2-wk and 4-wk of insole wear. Statistical analyses will be performed using SPSS 21.0 software. Two-way mixed ANOVA will be used to determine the immediate and short- and long-term effect of arch support insoles. The results of the current study are expected to provide evidences in supporting the use of arch support insoles for improving gait performance and postural stability for older adults with MCI which will contribute to balance and gait training as well as fall prevention.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2022

Completed
18 days until next milestone

First Submitted

Initial submission to the registry

July 19, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 22, 2022

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2022

Completed
Last Updated

July 22, 2022

Status Verified

July 1, 2022

Enrollment Period

6 months

First QC Date

July 19, 2022

Last Update Submit

July 21, 2022

Conditions

Outcome Measures

Primary Outcomes (6)

  • Change of static standing balance

    30-s static standing balance

    at baseline and after 2-wk and 4-wk of insole wear

  • Change of timed-up-and-go test

    3-m timed-up-and-go test

    at baseline and after 2-wk and 4-wk of insole wear

  • Change of 10-m obstacle crossing

    10-m obstacle crossing

    at baseline and after 2-wk and 4-wk of insole wear

  • Change of functional reach test

    functional reach test

    at baseline and after 2-wk and 4-wk of insole wear

  • Change of Short Physical Performance Battery

    Short Physical Performance Battery

    at baseline and after 2-wk and 4-wk of insole wear

  • Change of gait

    single- and dual-task walking for 20 m at self-selected comfortable pace while performing serial subtractions (cognitive interference) or carrying a tray (motor interference)

    at baseline and after 2-wk and 4-wk of insole wear

Study Arms (2)

experimental group

EXPERIMENTAL

wear the insoles for at least 4-h every day for 1-month

Device: arch support insoles (FootDisc)

control group

NO INTERVENTION

not wear insoles for at least 4-h every day for 1-month

Interventions

The FootDisc insole is designed with curEVA for shock absorption and motion reduction, poron for secondary heel and metatarsal protection, and dynamic arch support for returning energy for propulsion

experimental group

Eligibility Criteria

Age65 Years - 80 Years
Sexfemale
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • (1) female aged 65 years and over; (2) able to walk more than 20 m without walking aids; (3) had a Montreal Cognitive Assessment (MoCA) score lower than 26 ; (4) had self-reported memory complaints; and (5) had the ability to perform ADLs.

You may not qualify if:

  • (1) dementia; (2) a history of malignant tumors ; (3) the presence of an unstable neurological or orthopedic disease, or visual problems interfering with participation in the study; and (4) an education level less than 6 years (elementary school).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cardinal Tien Hospital

New Taipei City, Taiwan

RECRUITING

MeSH Terms

Conditions

Cognitive Dysfunction

Condition Hierarchy (Ancestors)

Cognition DisordersNeurocognitive DisordersMental Disorders

Study Officials

  • Chen-Yi Song

    National Taipei University of Nursing and Health Sciences

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

July 19, 2022

First Posted

July 22, 2022

Study Start

July 1, 2022

Primary Completion

December 31, 2022

Study Completion

December 31, 2022

Last Updated

July 22, 2022

Record last verified: 2022-07

Locations